Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847509 · ClinicalTrials.gov registry record · NA
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
A NA study, sponsored by Siemens Molecular Imaging.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00847509 is a NA study that has completed, run by Siemens Molecular Imaging. The registered enrollment target is 49 participants.
The verdict
NCT00847509, a NA study, has completed, sponsored by Siemens Molecular Imaging.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Approximately 60 patients will be enrolled with highly suspected lung cancer, or head and neck cancer. The patients must also be starting radiotherapy or a chemoradiotherapy regimen (except with 5-fluorouracil). The patients will undergo 3 visits. One screening, one pre therapy PET/CT imaging visit, and one (3-5 weeks after the start of therapy) post PET/CT imaging visit. This study will evaluate the FLT and FDG images for tumor proliferation rates for early assessment of tumor response to radiation or chemo-radiation combo.
Interventions
- DRUG [F-18]FLT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00847509
The ClinicalTrials.gov registry entry for NCT00847509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siemens Molecular Imaging, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [F-18]FLT is the first listed.
NCT00847509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00847509 about?
NCT00847509 is a clinical study titled "A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation". Approximately 60 patients will be enrolled with highly suspected lung cancer, or head and neck cancer. The patients must also be starting radiotherapy or a chemoradiotherapy regimen (except with 5-fluorouracil). The patients will undergo 3 visits. One screening, one pre therapy PET/CT imaging visit,...
What is the current status of trial NCT00847509?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2009-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00847509?
The interventions under investigation include: [F-18]FLT (DRUG).
Who is sponsoring clinical trial NCT00847509?
This trial is sponsored by Siemens Molecular Imaging, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.